Patent · US Active

IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

US8354436B2 · kind B2 · utility

2Cited by

0References

20Claims

0Family size

Assignee

4SC DISCOVERY GMBH · DE

Inventors

Johann Leban · Planegg, DE
Stefan Tasler · Hanerau-Hademarschen, DE
Wael Saeb · Gräfelfing, DE
Carine Chevrier · Munich, DE

Key dates

Filing date	Jan 27, 2012
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Jan 27, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.